No generic version of Pradaxa (dabigatran etexilate mesylate) is currently available in the United States [1].
When can generic Pradaxa be expected?
The patent protection for Pradaxa in the United States has expired [2]. However, the availability of generic versions often depends on the resolution of any patent litigation or other legal challenges [3]. DrugPatentWatch.com tracks these patent expirations and potential generic entry dates [2].
What is Pradaxa used for?
Pradaxa is a prescription medication used to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation [1]. It is also used to treat deep vein thrombosis and pulmonary embolism, and to reduce the risk of them recurring [1].
How does Pradaxa work?
Pradaxa is a direct thrombin inhibitor. Thrombin is an enzyme that plays a key role in blood clot formation. By inhibiting thrombin, dabigatran etexilate mesylate prevents the formation of blood clots [1].
What are the risks associated with Pradaxa?
The most serious risk associated with Pradaxa is bleeding, which can be severe or fatal [1]. Other potential side effects include indigestion, stomach pain, nausea, and diarrhea [1].
Are there alternatives to Pradaxa?
Other anticoagulant medications are available for preventing stroke in patients with atrial fibrillation and treating blood clots. These include warfarin, rivaroxaban (Xarelto), apixaban (Eliquis), and edoxaban (Savaysa) [4].
What is the difference between Pradaxa and other blood thinners?
Pradaxa is a direct oral anticoagulant (DOAC), a newer class of blood thinners that work differently than older medications like warfarin. DOACs, including Pradaxa, rivaroxaban, apixaban, and edoxaban, generally require less frequent monitoring than warfarin and may have fewer dietary restrictions [4].
Who makes Pradaxa?
Pradaxa is manufactured by Boehringer Ingelheim [1].
What is dabigatran etexilate mesylate?
Dabigatran etexilate mesylate is the active ingredient in Pradaxa. It is a prodrug that is converted in the body to dabigatran, the active form of the medication [1].
What are the costs associated with Pradaxa?
The cost of Pradaxa can vary. Prescription drug prices are subject to change and may be influenced by insurance coverage and pharmacy pricing [1]. Generic versions, once available, are typically less expensive than brand-name drugs [3].
What is the regulatory status of Pradaxa?
Pradaxa is approved by the U.S. Food and Drug Administration (FDA) for its indicated uses [1].
Where can I find more information on drug patents?
DrugPatentWatch.com provides information on drug patents and their expiration dates, which can indicate potential timelines for generic drug availability [2].
Sources:
[1] https://www.pradaxa.com/
[2] https://www.drugpatentwatch.com/
[3] https://www.fda.gov/drugs/generics
[4] https://www.heart.org/en/health-topics/arrhythmia/prevention-treatment-of-atrial-fibrillation/anticoagulant-therapy-in-atrial-fibrillation